SOC

Surgery on Children Journal aims to publish issues related to Pediatric Surgery, Pediatric Neurosurgery, Pediatric Plastic Surgery, Pediatric Cardiovascular Surgery, Pediatric Orthopedic Surgery, Pediatric Vascular Surgery, Pediatric Gynecology and Obstetrics, Pediatric Ear Nose Throat, Ophthalmology, Pediatric Anesthesiology and Reanimation, Pediatric Urology, Pediatric Surgical Intensive Care Clinic, and other clinical surgery fields on children of the highest scientific and clinical value at an international level and accepts articles on these topics.

EndNote Style
Index
Original Article
Fecal secretory immunoglobulin A (sIgA) levels in hirschsprung patients and normal children: a preliminary study
Aims: Hirschsprung’s disease (HD) is a congenital neurocristopathy characterized by distal colonic aganglionosis and is associated with an increased risk of enterocolitis and other postoperative complications. Impaired mucosal immunity, particularly alterations in secretory immunoglobulin A (sIgA), has been proposed as one of the contributing mechanisms. This study aimed to compare fecal sIgA levels between children with Hirschsprung’s disease without enterocolitis and healthy controls.
Methods: This exploratory cross-sectional study enrolled pediatric patients aged 2 months to <18 years between September and December 2024 from two referral hospitals and one primary health center. A total of 32 subjects were included: 16 children with histopathologically confirmed HD without enterocolitis and 16 healthy controls. Control participants had no congenital gastrointestinal abnormalities or recent gastrointestinal symptoms and showed normal findings on physical examination, routine stool analysis, and fecal occult blood testing. Fecal samples were analyzed using enzyme-linked immunosorbent assay to quantify sIgA levels. Data normality was assessed using the Shapiro–Wilk test, and group comparisons were performed using the Mann–Whitney U test.
Results: The median fecal sIgA level was 1551.56 µg/mL (27.69–35988.75) in the HD group and 771.87 µg/mL (31.27–11250.52) in controls. Although the median value was numerically higher in the HD group, the difference was not statistically significant (p = 0.72).
Conclusion: Children with HD without enterocolitis showed a numerically higher median fecal sIgA level than healthy controls, but no statistically significant difference was observed. These findings should be interpreted as exploratory baseline data rather than confirmatory evidence of clinical or mechanistic significance.


1. Ambartsumyan L, Smith C, Kapur RP. Diagnosis of Hirschsprung disease. Pediatr Dev Pathol. 2020;23(1):8-22. doi:10.1177/1093526619892351
2. Huang WK, Li XL, Zhang J, Zhang SC. Prevalence, risk factors, and prognosis of postoperative complications after surgery for Hirschsprung disease. J Gastrointest Surg. 2018;22(2):335-343. doi:10.1007/s11605-017-3596-6
3. Rintala RJ, Pakarinen MP. Long-term outcomes of Hirschsprung’s disease. Semin Pediatr Surg. 2012;21(4):336-343. doi:10.1053/j.sempedsurg.2012.07.008
4. Bai Y, Chen H, Hao J, Huang Y, Wang W. Long-term outcome and quality of life after the Swenson procedure for Hirschsprung’s disease. J Pediatr Surg. 2002;37(4):639-642. doi:10.1053/jpsu.2002.31625
5. Pabst O, Cerovic V, Hornef M. Secretory IgA in the coordination of establishment and maintenance of the microbiota. Trends Immunol. 2016;37(5):287-296. doi:10.1016/j.it.2016.03.002
6. Lewit RA, Kuruvilla KP, Fu M, Gosain A. Current understanding of Hirschsprung-associated enterocolitis: pathogenesis, diagnosis and treatment. Semin Pediatr Surg. 2022;31(2):151162. doi:10.1016/j.sempedsurg.2022.151162
7. Li S, Zhang Y, Li K, et al. Update on the pathogenesis of the Hirschsprung-associated enterocolitis. Int J Mol Sci. 2023;24(5):4602. doi:10.3390/ijms24054602
8. Ziogas IA, Kuruvilla KP, Fu M, Gosain A. Hirschsprung-associated enterocolitis: a comprehensive review. World J Pediatr Surg. 2024;7(3): e000878. doi:10.1136/wjps-2024-000878
9. Ostertag-Hill CA, Nandivada P, Dickie BH. Late diagnosis of Hirschsprung disease: clinical presentation and long-term functional outcomes. J Pediatr Surg. 2024;59(2):220-224. doi:10.1016/j.jpedsurg.2023.10.018
10. Pini Prato A, Erculiani M, Novi ML, et al. Delayed diagnosis in Hirschsprung disease. Pediatr Surg Int. 2024;40(1):65. doi:10.1007/s00383-024-05657-5
11. Wang D, Zhu T, Zhu L, et al. Screening of undernutrition in children with Hirschsprung disease using preoperative anthropometric parameters: a multicenter cross-sectional study. JPEN J Parenter Enteral Nutr. 2023;47(1):151-158. doi:10.1002/jpen.2440
12. Chen YY, Tun HM, Field CJ, et al. Impact of cesarean delivery and breastfeeding on secretory immunoglobulin A in the infant gut is mediated by gut microbiota and metabolites. Metabolites. 2023;13(2): 148. doi:10.3390/metabo13020148
13. Granger CL, Lamb CA, Embleton ND, et al. Secretory immunoglobulin A in preterm infants: determination of normal values in breast milk and stool. Pediatr Res. 2022;92(4):979-986. doi:10.1038/s41390-021-01930-8
14. Li P, Ren Z, Zhou J, et al. Effect of Lacticaseibacillus paracasei N1115 on immunomodulatory and gut microbial composition in young children: a randomized, placebo-controlled study. Nutrients. 2023;15(8):1970. doi:10.3390/nu15081970
15. Parker KD, Mueller JL, Westfal M, Goldstein AM, Ward NL. A pilot study characterizing longitudinal changes in fecal microbiota of patients with Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2022;38:1541-1553. doi:10.1007/s00383-022-05191-2
Volume 3, Issue 3, 2026
Page : 77-81
_Footer